Newsfeeds - Spark Newswire

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

November 25, 6:25 PM

Gainers XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 17.74% to $3.65 during Thursday's after-market session. The market value of their outstanding shares is at $19.2 million.

ASMB

3 minute read

28 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

November 24, 8:34 AM

Gainers Engine Gaming and Media, Inc. (NASDAQ: GAME) rose 51% to $4.80 in pre-market trading after the company reported Q4 2021 and FY21 revenue was higher year over year.

ADMP

5 minute read

56 Biggest Movers From Yesterday

By Lisa Levin

November 24, 5:59 AM

Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).

ADMP

5 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

November 23, 6:14 AM

Gainers

AEVA

3 minute read

40 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

November 22, 1:09 PM

Gainers

AHI

1 minute read

Gracell Biotech Stock Jumps On Orphan Drug Tag For Multiple Myeloma CAR-T Cell Therapy

By Vandana Singh

November 19, 9:54 AM

The FDA granted Orphan Drug Designation for Gracell Biotechnologies Inc’s (NASDAQ:GRCL) GC012F, FasTCAR-enabled BCMA/CD19 dual-targeting CAR-T cell therapy for multiple myeloma. The…

GRCL

5 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

November 19, 7:19 AM

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.

AEHR

1 minute read

Gracell Biotechnologies Q2 EPS $(0.04) Beats $(0.12) Estimate

By Bill Haddad

August 17, 7:09 AM

Gracell Biotechnologies (NASDAQ:GRCL) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.12) by 66.67 percent.

GRCL

2 minute read

Earnings Scheduled For August 17, 2021

By Benzinga Insights

August 17, 4:00 AM

Companies Reporting Before The Bell • AiHuiShou Intl (NYSE:RERE) is expected to report earnings for its second quarter.

2 minute read

Gracell Biotechnologies Signs Exclusive License Agreement With FutureGen Biopharm To Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 In Solid Tumors

By Bill Haddad

August 16, 8:25 AM

Gracell Biotechnologies Inc. (NASDAQ:GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer,

GRCL